Worsening of pretibial myxedema following radioiodine treatment for hyperthyroid Graves´ disease

Yotsapon Thewjitcharoen, Thep Himathongkam

PAMJ. 2023; 44:85. Published 14 Feb 2023 | doi:10.11604/pamj.2023.44.85.36177

The development of pretibial myxedema following RAI treatment has been occasionally reported from the probable influences of thyrotropin receptor antibodies (TRAbs) similar to the RAI-associated GO. Herein, we report an interesting case of the fluctuating clinical course of pretibial myxedema following treatments of hyperthyroid Graves' disease for over 3 years.
Corresponding author
Yotsapon Thewjitcharoen, Diabetes and Thyroid Center, Theptarin Hospital, Bangkok, Thailand (yotsapon_th@theptarin.com)

The Pan African Medical Journal (ISSN: 1937-8688) is a subsidiary of the Pan African Medical Journal. The contents of this journal is intended exclusively for professionals in the medical, paramedical and public health and other health sectors.

Currently tracked by: DOAJ, AIM, Google Scholar, AJOL, EBSCO, Scopus, Embase, IC, HINARI, Global Health, PubMed Central, PubMed/Medline, ESCI

Physical address: Kenya: 3rd Floor, Park Suite Building, Parkland Road, Nairobi. PoBox 38583-00100, tel: +254 (0)20-520-4356 | Cameroon: Immeuble TechnoPark Essos, Yaounde, PoBox: 10020 Yaounde, tel: +237 (0)24-309-5880